Literature DB >> 1296961

Beta-glucuronidase and hyperbilirubinemia in breast-fed versus formula-fed babies.

M S el-Kholy1, H Y Halim, A H Marzouk.   

Abstract

Breast milk and formula milk and the corresponding serum samples from 20 breast-fed babies, 20 formula-fed babies, and their mothers were examined at 3 days of age for beta-glucuronidase enzyme. Serum indirect bilirubin levels were also examined for all the infants. Serum indirect bilirubin concentrations were significantly higher (p < 0.001) in breast-fed (4.87 +/- 2.4 mg/dl) than in formula-fed infants (1.04 +/- 0.5 mg/dl). beta-glucuronidase activity in formula milk was negligible, while that in human milk was considerable (468.26 +/- 220.8 Sigma units/ml) and was correlated (p < 0.05) with that in the serum of the breast-fed (66.13 +/- 18.1 Sigma units/ml) than in formula fed infants (52.08 +/- 11.9 Sigma units/ml) and a significant (p < 0.05) correlation was found between its serum level and serum indirect bilirubin in both breast and formula fed infants. Also in breast-fed infants serum bilirubin concentrations were related to beta-glucuronidase activity in breast milk (p < 0.05): Breast milk beta-glucuronidase--by facilitating intestinal reabsorption of bilirubin--seems to be an important factor in the neonatal hyperbilirubinemia of breast-fed babies.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1296961

Source DB:  PubMed          Journal:  J Egypt Public Health Assoc        ISSN: 0013-2446


  2 in total

1.  Predicting drug-metagenome interactions: Variation in the microbial β-glucuronidase level in the human gut metagenomes.

Authors:  Moamen M Elmassry; Sunghwan Kim; Ben Busby
Journal:  PLoS One       Date:  2021-01-07       Impact factor: 3.240

2.  Gilbert or Crigler-Najjar syndrome? Neonatal severe unconjugated hyperbilirubinemia with P364L UGT1A1 homozygosity.

Authors:  Laura Cozzi; Federica Nuti; Irene Degrassi; Daniela Civeriati; Giulia Paolella; Gabriella Nebbia
Journal:  Ital J Pediatr       Date:  2022-04-18       Impact factor: 3.288

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.